CLINICAL_TRIALS ClinicalTrials.gov record update

Study to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals' Influenza Split Vaccine FLUARIX™ Administered According to the Prescribing Information in Korean Subjects Aged More Than 6 Months of Age at the Time of Vaccination

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00750360
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:06.174776+00:00
Published At: 2009-06-02T00:00:00+00:00
Record Updated At: 2018-11-06
Results Posted At: 2009-06-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Influenza"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-11-06"
protocolSection.identificationModule.nctId: "NCT00750360"
protocolSection.identificationModule.officialTitle: "Study to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals\u0027 Influenza Split Vaccine FLUARIX\u2122 Administered According to the Prescribing Information in Korean Subjects Aged More Than 6 Months of Age at the Time of Vaccination"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2009-06-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.